These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 23739158)

  • 41. [The predictive value of the ambulatory blood pressure monitoring parameters on left ventricular hypertrophy and carotid artery intima-media thickness in hypertensives].
    Wang DX; Zhao W; Sun YS; Tian QP; Chen Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Mar; 33(3):243-6. PubMed ID: 15929822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence and reproducibility of differences between home and ambulatory blood pressure and their relation with hypertensive organ damage.
    Gazzola K; Cammenga M; van der Hoeven NV; van Montfrans GA; van den Born BJH
    J Hum Hypertens; 2017 Sep; 31(9):555-560. PubMed ID: 28382957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of renal artery revascularization on left ventricular hypertrophy, diastolic function, blood pressure, and the one-year outcome.
    Rzeznik D; Przewlocki T; Kablak-Ziembicka A; Kozanecki A; Roslawiecka A; Lach J; Tracz W; Podolec P
    J Vasc Surg; 2011 Mar; 53(3):692-7. PubMed ID: 21129903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Factors influencing white-coat effect.
    Manios ED; Koroboki EA; Tsivgoulis GK; Spengos KM; Spiliopoulou IK; Brodie FG; Vemmos KN; Zakopoulos NA
    Am J Hypertens; 2008 Feb; 21(2):153-8. PubMed ID: 18174883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Target organ damage in children with newly diagnosed and untreated essential hypertension].
    Antoniewicz J; Litwin M; Daszkoska J; Niemirska A; Sladowska J; Wierzbicka A; Wawer Z; Grenda R
    Przegl Lek; 2006; 63 Suppl 3():101-6. PubMed ID: 16898502
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.
    Moyá A; Crespo JJ; Ayala DE; Ríos MT; Pousa L; Callejas PA; Salgado JL; Mojón A; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):116-31. PubMed ID: 23181613
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Blood pressure variability and its association with echocardiographic parameters in hypertensive diabetic patients.
    Massierer D; Leiria LF; Severo MD; Ledur Pdos S; Becker AD; Aguiar FM; Lima E; Freitas VC; Schaan BD; Gus M
    BMC Cardiovasc Disord; 2016 Jan; 16():4. PubMed ID: 26747793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Maximum value of home blood pressure: a novel indicator of target organ damage in hypertension.
    Matsui Y; Ishikawa J; Eguchi K; Shibasaki S; Shimada K; Kario K
    Hypertension; 2011 Jun; 57(6):1087-93. PubMed ID: 21536993
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalent influence of systolic over pulse pressure on left ventricular mass in essential hypertension.
    Verdecchia P; Schillaci G; Borgioni C; Gattobigio R; Ambrosio G; Porcellati C
    Eur Heart J; 2002 Apr; 23(8):658-65. PubMed ID: 11969281
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association Between Circadian Hemodynamic Characteristics and Target Organ Damage in Patients With Essential Hypertension.
    Kusunoki H; Iwashima Y; Kawano Y; Hayashi SI; Kishida M; Horio T; Shinmura K; Yoshihara F
    Am J Hypertens; 2019 Jul; 32(8):742-751. PubMed ID: 31211373
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ambulatory blood pressure thresholds for diagnosis of hypertension in patients with and without type 2 diabetes based on cardiovascular outcomes.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):132-44. PubMed ID: 23181634
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of left ventricular structural and functional abnormalities with aortic and brachial blood pressure variability in hypertensive patients: the SAFAR study.
    Chi C; Yu SK; Auckle R; Argyris AA; Nasothimiou E; Tountas C; Aissopou E; Blacher J; Safar ME; Sfikakis PP; Zhang Y; Protogerou AD
    J Hum Hypertens; 2017 Oct; 31(10):633-639. PubMed ID: 28569260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypertension-mediated organ damage regression associates with blood pressure variability improvement three years after successful treatment initiation in essential hypertension.
    Triantafyllidi H; Benas D; Schoinas A; Birmpa D; Trivilou P; Varytimiadi E; Voutsinos D; Ikonomidis I
    J Clin Hypertens (Greenwich); 2021 Jun; 23(6):1150-1158. PubMed ID: 33554428
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension.
    Verdecchia P; Angeli F; Gattobigio R; Rapicetta C; Reboldi G
    Am J Hypertens; 2007 Feb; 20(2):154-61. PubMed ID: 17261460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Weekly variation of home and ambulatory blood pressure and relation between arterial stiffness and blood pressure measurements in community-dwelling hypertensives.
    Murakami S; Otsuka K; Kubo Y; Shinagawa M; Matsuoka O; Yamanaka T; Nunoda S; Ohkawa S; Kitaura Y
    Clin Exp Hypertens; 2005; 27(2-3):231-9. PubMed ID: 15835386
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic syndrome, left ventricular hypertrophy and carotid atherosclerosis in hypertension: a gender-based study.
    Cuspidi C; Sala C; Lonati L; Negri F; Rescaldani M; Re A; Meani S; Mancia G
    Blood Press; 2013 Jun; 22(3):138-43. PubMed ID: 23181484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension.
    Hermida RC; Ríos MT; Crespo JJ; Moyá A; Domínguez-Sardiña M; Otero A; Sánchez JJ; Mojón A; Fernández JR; Ayala DE;
    Chronobiol Int; 2013 Mar; 30(1-2):192-206. PubMed ID: 23098160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nighttime home blood pressure and the risk of hypertensive target organ damage.
    Ishikawa J; Hoshide S; Eguchi K; Ishikawa S; Shimada K; Kario K;
    Hypertension; 2012 Oct; 60(4):921-8. PubMed ID: 22892810
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Awake blood pressure variability, inflammatory markers and target organ damage in newly diagnosed hypertension.
    Tatasciore A; Zimarino M; Renda G; Zurro M; Soccio M; Prontera C; Emdin M; Flacco M; Schillaci G; DE Caterina R
    Hypertens Res; 2008 Dec; 31(12):2137-46. PubMed ID: 19139603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.